(Q61936640)
Statements
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Asian Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise (English)
0 references
June 2010
0 references
March 2012
0 references
1,179
0 references
18 year
0 references